COVID-19 during pregnancy
Conditions
Interventions
None
Sponsors
Máxima MC
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women who tested positive on SARS-CoV-2, regardless of the presence or absence of any clinical symptoms
Exclusion criteria
Exclusion criteria: Women <18 years old
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To describe the clinical presentation (symptoms) of pregnant women who tested positive on SARS-CoV-2 -To describe the clinical course of COVID-19 infection during pregnancy | — |
Secondary
| Measure | Time frame |
|---|---|
| -To describe riskfactors associated with a severe clinical course of COVID-19 during pregnancy (severe clinical course is defined as: admission to intensive care unit of in case of mortality) -To describe the number of transmission of SARS-CoV-2 from mother to neonate and when possible determine factors associated with an increased risk of transmission (e.g. breastfeeding) -To evaluate/describe any treatments given during admission -To describe whether COVID-19 might be associated with preterm birth, intrauterine growth restriction of neonatal congenital disorders | — |
Contacts
Public ContactMarion Frenken
Máxima Medisch Centrum, Veldhoven
Outcome results
None listed